Le Lézard1h
Cycle Vitatm expands patient support in Multiple Sclerosis (MS) to include BAFIERTAM® (monomethyl fumarate) delayed-release capsules
Cycle Pharmaceuticals Limited (Cycle) is pleased to announce that Cycle Vita is now available with BAFIERTAM, expanding its patient support services in MS, following the acquisition of Banner Life ...
Le Lézard3h
BeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
BeiGene, Ltd. , a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...
Macau Business2h
Ascletis Announces Positive Interim Results from Its U.S. Phase Ib Trial with ASC30, a Potentially...
Ascletis Pharma Inc. (HKEX:1672, “Ascletis”) today announces positive interim results from its randomized, double-blind, placebo-controlled Phase Ib single subcutaneous (SQ) injection study ( ...